Skip to main content

Advertisement

Log in

The role of FDG PET/CT in therapy control of aortic graft infection

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

18F-FDG PET/CT (PET/CT) is a useful tool for the diagnosis of aortic graft infection (AGI), but has rarely been used to influence therapeutic decisions during follow-up. We aimed to study the role of PET/CT in the long-term monitoring of patients.

Methods

Participants of the prospective Vascular Graft Infection Cohort Study (VASGRA) were included if they had microbiologically proven AGI. We quantified the metabolic activity in PET/CT by using maximum standardized uptake value (SUVmax) and further classified it as being focal or diffuse. Multivariable linear regression models were fit using generalized estimating equations to investigate factors associated with SUVmax over time.

Results

Sixty-eight participants with AGI contributed to 266 PET/CTs including 36 examinations performed after stop of antimicrobial therapy. Higher C-reactive protein (CRP) (adjusted coefficient per log10 mg/L 0.05 [95% C.I. 0.02–0.08]) was associated with higher SUVmax. CRP, metabolic and clinical findings informed the decision to either start (medians of SUVmax 7.1 and CRP 31.5 mg/L; 100% focal uptake), escalate (SUVmax 9.5; CRP 31.5; 100% focal uptake), continue (SUVmax 6.0; CRP 9.95 mg/L; 90% focal uptake), or stop (SUVmax 4.3; CRP 3.5 mg/L; 61% focal uptake) antibiotic treatment. Of note, decisions to escalate or continue antibiotic treatment were taken despite normal CRP values in 12.5 and 35.7% of PET/CTs, respectively.

Conclusions

Consecutive PET/CTs could influence the clinical decision-making in patients with AGI in the near future. More studies on the use of PET/CT in case of aortic graft infection may offer the potential for individualized treatment approaches.

CLINICALTRIALS.GOV IDENTIFIER

NCT01821664.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Caillaux M, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect. 2011. https://doi.org/10.1111/j.1469-0691.2011.03618.x.

  2. Hasse B, Husmann L, Zinkernagel A, Weber R, Lachat M, Mayer D. Vascular graft infections. Swiss Med Wkly. 2013;143:w13754. https://doi.org/10.4414/smw.2013.13754.

    Article  PubMed  Google Scholar 

  3. Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, O'Gara PT, Lockhart PB, et al. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. Circulation. 2016;134:e412–e60. https://doi.org/10.1161/CIR.0000000000000457.

    Article  PubMed  Google Scholar 

  4. Antonios VS, Noel AA, Steckelberg JM, Wilson WR, Mandrekar JN, Harmsen WS, et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Inf Secur. 2006;53:49–55. https://doi.org/10.1016/j.jinf.2005.10.004.

    Article  Google Scholar 

  5. Turtiainen J, Saimanen E, Partio T, Karkkainen J, Kiviniemi V, Makinen K, et al. Surgical wound infections after vascular surgery: prospective multicenter observational study. Scand J Surg. 2010;99:167–72. https://doi.org/10.1177/145749691009900312.

    Article  PubMed  CAS  Google Scholar 

  6. Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg. 2008;47:264–9. https://doi.org/10.1016/j.jvs.2007.10.030.

    Article  PubMed  Google Scholar 

  7. Low RN, Wall SD, Jeffrey RB, Jr., Sollitto RA, Reilly LM, Tierney LM, Jr. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology 1990;175:157–162. https://doi.org/10.1148/radiology.175.1.2315475.

  8. Mark A, Moss AA, Lusby R, Kaiser JA. CT evaluation of complications of abdominal aortic surgery. Radiology. 1982;145:409–14. https://doi.org/10.1148/radiology.145.2.6982487.

    Article  PubMed  CAS  Google Scholar 

  9. Fiorani P, Speziale F, Rizzo L, De Santis F, Massimi GJ, Taurino M, et al. Detection of aortic graft infection with leukocytes labeled with technetium 99m-hexametazime. J Vasc Surg. 1993;17:87–95. discussion -6

    Article  PubMed  CAS  Google Scholar 

  10. Bruggink JL, Glaudemans AW, Saleem BR, Meerwaldt R, Alkefaji H, Prins TR, et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery. 2010;40:348–54. https://doi.org/10.1016/j.ejvs.2010.05.016.

    Article  CAS  Google Scholar 

  11. Fukuchi K, Ishida Y, Higashi M, Tsunekawa T, Ogino H, Minatoya K, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg. 2005;42:919–25. https://doi.org/10.1016/j.jvs.2005.07.038.

    Article  PubMed  Google Scholar 

  12. Keidar Z, Engel A, Hoffman A, Israel O, Nitecki S. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2007;48:1230–6. https://doi.org/10.2967/jnumed.107.040253.

    Article  Google Scholar 

  13. Sah BR, Husmann L, Mayer D, Scherrer A, Rancic Z, Puippe G, et al. Diagnostic Performance of F-FDG-PET/CT in Vascular Graft Infections. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery. 2015. https://doi.org/10.1016/j.ejvs.2014.12.024.

  14. Husmann L, Sah BR, Scherrer A, Burger IA, Stolzmann P, Weber R, et al. (1)(8)F-FDG PET/CT for Therapy Control in Vascular Graft Infections: A First Feasibility Study. J Nucl Med. 2015;56:1024–9. https://doi.org/10.2967/jnumed.115.156265.

    Article  PubMed  Google Scholar 

  15. Lyons OT, Baguneid M, Barwick TD, Bell RE, Foster N, Homer-Vanniasinkam S, et al. Diagnosis of Aortic Graft Infection: A Case Definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52:758–63. https://doi.org/10.1016/j.ejvs.2016.09.007.

    Article  PubMed  CAS  Google Scholar 

  16. Samson RH, Veith FJ, Janko GS, Gupta SK. Scher LA. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg. 1988;8:147–53.

    Article  PubMed  CAS  Google Scholar 

  17. Mayer D, Hasse B, Koelliker J, Enzler M, Veith FJ, Rancic Z, et al. Long-term results of vascular graft and artery preserving treatment with negative pressure wound therapy in Szilagyi grade III infections justify a paradigm shift. Ann Surg. 2011;254:754–9; discussion 60. https://doi.org/10.1097/SLA.0b013e3182365864.

    Article  PubMed  Google Scholar 

  18. Ankrah AO, Glaudemans A, Klein HC, Dierckx R, Sathekge M. The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases. Nucl Med Mol Imaging. 2017;51:127–39. https://doi.org/10.1007/s13139-016-0422-0.

    Article  PubMed  CAS  Google Scholar 

  19. Seban RD, Bonardel G, Guernou M, Lussato D, Queneau M. The Use of FDG PET-CT Imaging for the Assessment of Early Antifungal Treatment Response in Disseminated Fusariosis. Clin Nucl Med. 2017;42:569–70. https://doi.org/10.1097/RLU.0000000000001682.

    Article  PubMed  Google Scholar 

  20. Dejust S, Guedec-Ghelfi R, Blanc-Autrant E, Lepers Y, Morland D. Infection of Ventricular Assist Device Detected and Monitored by 18F-FDG PET/CT. Clin Nucl Med. 2017. https://doi.org/10.1097/RLU.0000000000001736.

  21. Chacko AM, Watanabe S, Herr KJ, Kalimuddin S, Tham JY, Ong J, et al. 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response. JCI Insight. 2017;2 https://doi.org/10.1172/jci.insight.93474.

  22. Lefebvre N, Argemi X, Meyer N, Mootien J, Douiri N, Sferrazza-Mandala S, et al. Clinical usefulness of 18F-FDG PET/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis. Nucl Med Biol. 2017;50:17–24. https://doi.org/10.1016/j.nucmedbio.2017.04.003.

    Article  PubMed  CAS  Google Scholar 

  23. Machelart I, Greib C, Wirth G, Camou F, Issa N, Viallard JF, et al. Graft infection after a Bentall procedure: A case series and systematic review of the literature. Diagn Microbiol Infect Dis. 2017;88:158–62. https://doi.org/10.1016/j.diagmicrobio.2017.03.002.

    Article  PubMed  CAS  Google Scholar 

  24. Deipolyi AR, Rho J, Khademhosseini A, Oklu R. Diagnosis and management of mycotic aneurysms. Clin Imaging. 2016;40:256–62. https://doi.org/10.1016/j.clinimag.2015.11.011.

    Article  PubMed  Google Scholar 

  25. Kagna O, Kurash M, Ghanem-Zouabi N, Keidar Z, Israel O. Does antibiotic treatment affect the diagnostic accuracy of FDG PET/CT studies in patients with suspected infectious processes? Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2017. https://doi.org/10.2967/jnumed.117.192062.

  26. Spacek M, Belohlavek O, Votrubova J, Sebesta P, Stadler P. Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging. 2009;36:850–8. https://doi.org/10.1007/s00259-008-1002-z.

    Article  PubMed  CAS  Google Scholar 

  27. Keidar Z, Pirmisashvili N, Leiderman M, Nitecki S, Israel O. 18F-FDG Uptake in Noninfected Prosthetic Vascular Grafts: Incidence, Patterns, and Changes over Time. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2014;55:392–5. https://doi.org/10.2967/jnumed.113.128173.

    Article  CAS  Google Scholar 

  28. Rabkin Z, Israel O, Keidar Z. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2010;51:1015–20. https://doi.org/10.2967/jnumed.109.074294.

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to our patients for their commitment and thank B. Ruehe, C. Rüegg, A. Wolfensberger, U. Matt, M. Kälin and M. Greiner for excellent patient care. We also thank C. Müller and S. Bürgin, study nurses and C. Vögtli for administrative assistance.

The members of the VASGRA Cohort Study are (in alphabetical order): A. Anagnosto-poulos, B. Hasse (Principle investigator), L. Husmann, B. Ledergerber, M. Lachat, D. Mayer, Z. Rancic, A. Scherrer, A. Weber, R. Weber, R. Zbinden, A. Zinkernagel.

Funding

This study was financed within the framework of the Vascular Graft Cohort Study (VASGRA), supported by the Swiss National Science Foundation (SNF) grant #32473B_163132/1, a SNF protected-research-time for clinicans grant #32473B_163132/2; the Vontobel Foundation and the Rozalia Foundation (all to BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

BH and LH designed the study. BL analyzed the data. LH and BH wrote the first draft, and LH, BL, AA and BH wrote the final version of the manuscript. All investigators contributed to collection and interpretation of the data, reviewed drafts of the manuscript, and approved the final manuscript.

Corresponding author

Correspondence to Lars Husmann.

Ethics declarations

Conflict of Interest

All authors declare no conflicts of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Institutional Review Board approved the study, and we obtained written informed consent from all participants (KEK-ZH-Nr. 2012–0583).

Electronic supplementary material

ESM 1

(PDF 129 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Husmann, L., Ledergerber, B., Anagnostopoulos, A. et al. The role of FDG PET/CT in therapy control of aortic graft infection. Eur J Nucl Med Mol Imaging 45, 1987–1997 (2018). https://doi.org/10.1007/s00259-018-4069-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-018-4069-1

Keywords

Navigation